1型糖尿病并医疗补助保险青少年的自我血糖监测与持续葡萄糖监测的关联
本研究回顾性纳入两个大型医疗系统的78例1型糖尿病并医疗补助保险青少年,按基线自我血糖监测频率(<4次/日 vs ≥4次/日)分组,随访6个月。两组持续葡萄糖监测依从性在3个月和6个月时相似,HbA1c在两组均改善,基线监测<4次/日组改善幅度更大。作者认为将持续葡萄糖监测限制于每日自我血糖监测≥4次者是不必要的障碍。
要点
- 基线自我血糖监测<4次/日与≥4次/日两组,持续葡萄糖监测依从性在3个月时相似(68.7% vs 68.4%,P=0.97),6个月时维持。
- 两组HbA1c在3个月时均改善,基线自我血糖监测<4次/日组改善幅度更大(1.3% vs 0.4%),6个月时维持。
- 患者调查(n=35)报告对持续葡萄糖监测参与度高,启动后胰岛素大剂量注射次数增加。
核心结论
- 使用持续葡萄糖监测的患者无论既往自我血糖监测频率如何,HbA1c均改善;将持续葡萄糖监测限制于每日自我血糖监测≥4次者是不必要的障碍,可能排除最可能受益的患者。
研究设计与样本
- 回顾性研究,纳入2019年1月后启动持续葡萄糖监测(新型号无需校准)的1型糖尿病并医疗补助保险青少年,来自两个大型医疗系统,共78例,随访6个月。
主要发现
- 持续葡萄糖监测依从性在基线自我血糖监测<4次/日组与≥4次/日组之间3个月时相似(68.7% vs 68.4%,P=0.97),并持续至6个月。
- 两组HbA1c在3个月时均改善,基线自我血糖监测<4次/日组改善幅度更大(1.3% vs 0.4%),并持续至6个月。
- 患者调查(n=35)报告对持续葡萄糖监测参与度高,启动后胰岛素大剂量注射次数增加。
临床怎么用
- 作者认为,将持续葡萄糖监测限制于每日自我血糖监测≥4次者是不必要的障碍,可能排除最可能受益的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Youth with type 1 diabetes (T1D) and Medicaid must demonstrate they have self-monitored their blood glucose level at least four times daily to receive continuous glucose monitors (CGMs). New California Medicaid policies eliminated this requirement and, thus, CGM access has increased. This study examines whether infrequent baseline self-monitored blood glucose (SMBG) checks result in suboptimal outcomes or nonadherence with CGM use. RESEARCH DESIGN AND METHODS: This retrospective study included youth with T1D and Medicaid who started CGM after January 2019, when newer models no longer needed calibration, at two large health care systems. Patients were stratified by data on baseline SMBG frequency (<4 vs. ≥4 checks daily) collected at the clinic visit prior to starting CGM. Differences between SMBG groups in CGM adherence and HbA1c over time were assessed by a mixed-effects linear regression model and fixed-effect interaction term. Patients were surveyed to explore individual impact of CGM on diabetes management. RESULTS: We followed 78 youth for 6 months. CGM adherence was similar between SMBG frequency groups at 3 months (68.7% vs. 68.4%; P = 0.97) and sustained at 6 months. HbA1c values improved in both groups at 3 months, with a larger improvement in those with SMBG <4 daily checks (1.3% vs. 0.4%), and sustained at 6 months. Patient surveys (n = 35) reported high engagement with CGM and increased insulin boluses after initiation. CONCLUSIONS: Patients using CGM demonstrated improvement in HbA1c regardless of prior SMBG. Increased engagement with CGM likely promoted increased insulin boluses. Therefore, restriction of CGM to those with SMBG ≥4 daily checks is an unnecessary barrier, excluding those who could potentially benefit the most.
引用
- Chan J, Jackson N, Gonzalez Rebollar A, et al. Association Between Self-Monitored Blood Glucose and Continuous Glucose Monitoring in Youth With Type 1 Diabetes and Medicaid Insurance. Diabetes Care. 2025. PMID: 39950997. doi:10.2337/dc24-2224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。